Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Blasi

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Biosensors & Bioelectronics|June 22, 2005
Formation and characterization of glutamate dehydrogenase monolayers on silicon supportsL Blasi, L Longo, P P Pompa, et al.
ESMO Open|December 20, 2023
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD)L Incorvaia, G Badalamenti, G Novo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2025
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trialD Ciardiello, G Martini, L Boscolo Bielo, et al.
ESMO Open|June 24, 2025
Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trialD Ciardiello, L Boscolo Bielo, F Pietrantonio, et al.
Breast (Edinburgh, Scotland)|July 17, 2017
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA studyM E Cazzaniga, M Airoldi, V Arcangeli, et al.
ESMO Open|October 29, 2025
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapyL Boscolo Bielo, S Napolitano, A Avallone, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Biosensors & Bioelectronics|June 22, 2005
Formation and characterization of glutamate dehydrogenase monolayers on silicon supportsL Blasi, L Longo, P P Pompa, et al.
ESMO Open|December 20, 2023
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD)L Incorvaia, G Badalamenti, G Novo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2025
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trialD Ciardiello, G Martini, L Boscolo Bielo, et al.
ESMO Open|June 24, 2025
Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trialD Ciardiello, L Boscolo Bielo, F Pietrantonio, et al.
Breast (Edinburgh, Scotland)|July 17, 2017
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA studyM E Cazzaniga, M Airoldi, V Arcangeli, et al.
ESMO Open|October 29, 2025
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapyL Boscolo Bielo, S Napolitano, A Avallone, et al.
Pageof 3